Practice/Industry Group Overview
Our Intellectual Property Litigation practice focuses on the prosecution and defense of intellectual property infringement, misuse, dilution and unfair competition claims. Our intellectual property litigation attorneys are proud to call themselves trial attorneys. They have extensive experience in core technical sciences, intellectual property theories, commercial relationships and economics. They prepare intellectual property litigation strategies in close association with our patent, trademark, copyright, antitrust, franchise and technology attorneys.
As trial advocates, our intellectual property trial attorneys have successfully prosecuted and defended infringement, misappropriation and unfair competition claims before:
- U.S. Patent and Trademark Office
- International Trade Commission
- U.S. Customs Service
- Federal Trade Commission
- Food and Drug Administration
- World Intellectual Property Organization Arbitration and Mediation Forum
- Trademark Trial and Appeal Board
- U.S. District Courts and Circuit Courts of Appeal
- U.S. Supreme Court
Our intellectual property litigation attorneys have attained hard-earned reputations for winning complex business verdicts. Equally important, as trial attorneys they are frequently engaged in the design of risk management and case resolution strategies, and their trial talents are never seen. Our trial attorneys understand the commercial value of aggressive litigation prosecutions and artfully timed, carefully negotiated litigation settlements.
Leading intellectual property litigation strategy and creative solutions result from our trial attorneys understanding our clients’ intellectual property approaches and risk tolerances, and applying their substantive knowledge of intellectual property laws.
We have one of the premier ANDA/generic drug patent litigation practices in the country. We have a proven record of success in these cases having successfully invalidated Pfizer’s patent directed to its multi-billion dollar drug Norvasc®. We also were successful in knocking out Daiichi Sankyo Co., Ltd.’s patent on Floxin® otic, in a case that resulted in a $5 million award to our generic client. Our attorneys have handled or are presently handling several major ANDA litigations, including cases involving Plavix®, Abilify®, Uroxatral®, Boniva®, Eloxatin®, Ultracet®, Wellbutrin XL®, Strattera®, Adderall XR®, Clarinex®, Amrix®, Enablex®, and Cymbalta®. We also have experience in related FDA and regulatory matters involving marketing approval for generic drugs under the Hatch-Waxman Act. This experience and understanding of the Hatch-Waxman regulatory scheme is critical in crafting successful patent litigation strategy.
Our approach to intellectual property litigation, including suits involving patents, is unique in that we provide our clients with a team of experts to handle each case in the most expeditious and cost-effective manner possible. Each case is carefully analyzed to determine the breadth of technical expertise that is necessary. Then, a team led by an experienced trial lawyer is selected and each member of that team brings value and efficiency to the execution of that strategy.
We have more than 90 attorneys dedicated to intellectual property and technology law, including patents, trademarks, copyrights, unfair competition, trade secrets, advertising, licensing, e-commerce, entertainment and media, and intellectual property litigation. We have represented multi-national and middle-market corporations in patent, trademark and other intellectual property matters across the country. Three of our intellectual property litigation attorneys are listed in The Best Lawyers in America 2009.